SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001587221-20-000029
Filing Date
2020-08-17
Accepted
2020-08-17 16:20:11
Documents
14
Period of Report
2020-08-14
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K zsan-20200814.htm   iXBRL 8-K 43648
  Complete submission text file 0001587221-20-000029.txt   188697

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT zsan-20200814.xsd EX-101.SCH 2435
3 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT zsan-20200814_cal.xml EX-101.CAL 718
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT zsan-20200814_def.xml EX-101.DEF 1651
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT zsan-20200814_lab.xml EX-101.LAB 24975
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT zsan-20200814_pre.xml EX-101.PRE 13195
7 EXTRACTED XBRL INSTANCE DOCUMENT zsan-20200814_htm.xml XML 11170
Mailing Address 34790 ARDENTECH COURT FREMONT CA 94555
Business Address 34790 ARDENTECH COURT FREMONT CA 94555 510-745-1200
Zosano Pharma Corp (Filer) CIK: 0001587221 (see all company filings)

IRS No.: 454488360 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36570 | Film No.: 201110364
SIC: 2834 Pharmaceutical Preparations